Pharma & Healthcare
Global Pneumococcal Vaccine Market Research Report 2025
- Mar 11, 25
- ID: 27944
- Pages: 74
- Figures: 74
- Views: 13
The global market for Pneumococcal Vaccine was valued at US$ 7358 million in the year 2024 and is projected to reach a revised size of US$ 7935 million by 2031, growing at a CAGR of 1.1% during the forecast period.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine.
The Pneumococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
By Company
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Segment by Type
PPSV 23
PCV 7/13
PCV 10
Segment by End User
Child
Adult
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine.
The Pneumococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End User, and by regions.
By Company
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Segment by Type
PPSV 23
PCV 7/13
PCV 10
Segment by End User
Child
Adult
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Pneumococcal Vaccine Market Overview
1.1 Product Definition
1.2 Pneumococcal Vaccine by Type
1.2.1 Global Pneumococcal Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Pneumococcal Vaccine by End User
1.3.1 Global Pneumococcal Vaccine Market Value by End User (2024 VS 2031)
1.3.2 Child
1.3.3 Adult
1.4 Global Pneumococcal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Vaccine Revenue 2020-2031
1.4.2 Global Pneumococcal Vaccine Sales 2020-2031
1.4.3 Global Pneumococcal Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pneumococcal Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pneumococcal Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pneumococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
2.8 Global Pneumococcal Vaccine Market Competitive Situation and Trends
2.8.1 Global Pneumococcal Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pneumococcal Vaccine Players Market Share by Revenue
2.8.3 Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal Vaccine Market Scenario by Region
3.1 Global Pneumococcal Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pneumococcal Vaccine Sales by Region: 2020-2031
3.2.1 Global Pneumococcal Vaccine Sales by Region: 2020-2025
3.2.2 Global Pneumococcal Vaccine Sales by Region: 2026-2031
3.3 Global Pneumococcal Vaccine Revenue by Region: 2020-2031
3.3.1 Global Pneumococcal Vaccine Revenue by Region: 2020-2025
3.3.2 Global Pneumococcal Vaccine Revenue by Region: 2026-2031
3.4 North America Pneumococcal Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pneumococcal Vaccine Sales by Country (2020-2031)
3.4.3 North America Pneumococcal Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pneumococcal Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pneumococcal Vaccine Sales by Country (2020-2031)
3.5.3 Europe Pneumococcal Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pneumococcal Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Pneumococcal Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pneumococcal Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pneumococcal Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Pneumococcal Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pneumococcal Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pneumococcal Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pneumococcal Vaccine Sales by Type (2020-2031)
4.1.1 Global Pneumococcal Vaccine Sales by Type (2020-2025)
4.1.2 Global Pneumococcal Vaccine Sales by Type (2026-2031)
4.1.3 Global Pneumococcal Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Pneumococcal Vaccine Revenue by Type (2020-2031)
4.2.1 Global Pneumococcal Vaccine Revenue by Type (2020-2025)
4.2.2 Global Pneumococcal Vaccine Revenue by Type (2026-2031)
4.2.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Pneumococcal Vaccine Price by Type (2020-2031)
5 Segment by End User
5.1 Global Pneumococcal Vaccine Sales by End User (2020-2031)
5.1.1 Global Pneumococcal Vaccine Sales by End User (2020-2025)
5.1.2 Global Pneumococcal Vaccine Sales by End User (2026-2031)
5.1.3 Global Pneumococcal Vaccine Sales Market Share by End User (2020-2031)
5.2 Global Pneumococcal Vaccine Revenue by End User (2020-2031)
5.2.1 Global Pneumococcal Vaccine Revenue by End User (2020-2025)
5.2.2 Global Pneumococcal Vaccine Revenue by End User (2026-2031)
5.2.3 Global Pneumococcal Vaccine Revenue Market Share by End User (2020-2031)
5.3 Global Pneumococcal Vaccine Price by End User (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Pneumococcal Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 MSD
6.3.1 MSD Company Information
6.3.2 MSD Description and Business Overview
6.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 MSD Pneumococcal Vaccine Product Portfolio
6.3.5 MSD Recent Developments/Updates
6.4 Sanofipasteur
6.4.1 Sanofipasteur Company Information
6.4.2 Sanofipasteur Description and Business Overview
6.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
6.4.5 Sanofipasteur Recent Developments/Updates
6.5 CDIBP
6.5.1 CDIBP Company Information
6.5.2 CDIBP Description and Business Overview
6.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
6.5.5 CDIBP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Vaccine Industry Chain Analysis
7.2 Pneumococcal Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Vaccine Production Mode & Process Analysis
7.4 Pneumococcal Vaccine Sales and Marketing
7.4.1 Pneumococcal Vaccine Sales Channels
7.4.2 Pneumococcal Vaccine Distributors
7.5 Pneumococcal Vaccine Customer Analysis
8 Pneumococcal Vaccine Market Dynamics
8.1 Pneumococcal Vaccine Industry Trends
8.2 Pneumococcal Vaccine Market Drivers
8.3 Pneumococcal Vaccine Market Challenges
8.4 Pneumococcal Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pneumococcal Vaccine by Type
1.2.1 Global Pneumococcal Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Pneumococcal Vaccine by End User
1.3.1 Global Pneumococcal Vaccine Market Value by End User (2024 VS 2031)
1.3.2 Child
1.3.3 Adult
1.4 Global Pneumococcal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Vaccine Revenue 2020-2031
1.4.2 Global Pneumococcal Vaccine Sales 2020-2031
1.4.3 Global Pneumococcal Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pneumococcal Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pneumococcal Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pneumococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
2.8 Global Pneumococcal Vaccine Market Competitive Situation and Trends
2.8.1 Global Pneumococcal Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pneumococcal Vaccine Players Market Share by Revenue
2.8.3 Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal Vaccine Market Scenario by Region
3.1 Global Pneumococcal Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pneumococcal Vaccine Sales by Region: 2020-2031
3.2.1 Global Pneumococcal Vaccine Sales by Region: 2020-2025
3.2.2 Global Pneumococcal Vaccine Sales by Region: 2026-2031
3.3 Global Pneumococcal Vaccine Revenue by Region: 2020-2031
3.3.1 Global Pneumococcal Vaccine Revenue by Region: 2020-2025
3.3.2 Global Pneumococcal Vaccine Revenue by Region: 2026-2031
3.4 North America Pneumococcal Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pneumococcal Vaccine Sales by Country (2020-2031)
3.4.3 North America Pneumococcal Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pneumococcal Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pneumococcal Vaccine Sales by Country (2020-2031)
3.5.3 Europe Pneumococcal Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pneumococcal Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Pneumococcal Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pneumococcal Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pneumococcal Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Pneumococcal Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pneumococcal Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pneumococcal Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pneumococcal Vaccine Sales by Type (2020-2031)
4.1.1 Global Pneumococcal Vaccine Sales by Type (2020-2025)
4.1.2 Global Pneumococcal Vaccine Sales by Type (2026-2031)
4.1.3 Global Pneumococcal Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Pneumococcal Vaccine Revenue by Type (2020-2031)
4.2.1 Global Pneumococcal Vaccine Revenue by Type (2020-2025)
4.2.2 Global Pneumococcal Vaccine Revenue by Type (2026-2031)
4.2.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Pneumococcal Vaccine Price by Type (2020-2031)
5 Segment by End User
5.1 Global Pneumococcal Vaccine Sales by End User (2020-2031)
5.1.1 Global Pneumococcal Vaccine Sales by End User (2020-2025)
5.1.2 Global Pneumococcal Vaccine Sales by End User (2026-2031)
5.1.3 Global Pneumococcal Vaccine Sales Market Share by End User (2020-2031)
5.2 Global Pneumococcal Vaccine Revenue by End User (2020-2031)
5.2.1 Global Pneumococcal Vaccine Revenue by End User (2020-2025)
5.2.2 Global Pneumococcal Vaccine Revenue by End User (2026-2031)
5.2.3 Global Pneumococcal Vaccine Revenue Market Share by End User (2020-2031)
5.3 Global Pneumococcal Vaccine Price by End User (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Pneumococcal Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 MSD
6.3.1 MSD Company Information
6.3.2 MSD Description and Business Overview
6.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 MSD Pneumococcal Vaccine Product Portfolio
6.3.5 MSD Recent Developments/Updates
6.4 Sanofipasteur
6.4.1 Sanofipasteur Company Information
6.4.2 Sanofipasteur Description and Business Overview
6.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
6.4.5 Sanofipasteur Recent Developments/Updates
6.5 CDIBP
6.5.1 CDIBP Company Information
6.5.2 CDIBP Description and Business Overview
6.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
6.5.5 CDIBP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Vaccine Industry Chain Analysis
7.2 Pneumococcal Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Vaccine Production Mode & Process Analysis
7.4 Pneumococcal Vaccine Sales and Marketing
7.4.1 Pneumococcal Vaccine Sales Channels
7.4.2 Pneumococcal Vaccine Distributors
7.5 Pneumococcal Vaccine Customer Analysis
8 Pneumococcal Vaccine Market Dynamics
8.1 Pneumococcal Vaccine Industry Trends
8.2 Pneumococcal Vaccine Market Drivers
8.3 Pneumococcal Vaccine Market Challenges
8.4 Pneumococcal Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pneumococcal Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pneumococcal Vaccine Market Value by End User (2024 VS 2031) & (US$ Million)
Table 3. Global Pneumococcal Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pneumococcal Vaccine Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pneumococcal Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pneumococcal Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pneumococcal Vaccine Average Price (USD/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pneumococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pneumococcal Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pneumococcal Vaccine Sales by Region (2020-2025) & (K Doses)
Table 18. Global Pneumococcal Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Pneumococcal Vaccine Sales by Region (2026-2031) & (K Doses)
Table 20. Global Pneumococcal Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Pneumococcal Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pneumococcal Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Pneumococcal Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pneumococcal Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Pneumococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 27. North America Pneumococcal Vaccine Sales by Country (2026-2031) & (K Doses)
Table 28. North America Pneumococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pneumococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pneumococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Pneumococcal Vaccine Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Pneumococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pneumococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pneumococcal Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pneumococcal Vaccine Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Pneumococcal Vaccine Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Pneumococcal Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pneumococcal Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pneumococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Pneumococcal Vaccine Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Pneumococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pneumococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pneumococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East and Africa Pneumococcal Vaccine Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East and Africa Pneumococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pneumococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pneumococcal Vaccine Sales (K Doses) by Type (2020-2025)
Table 51. Global Pneumococcal Vaccine Sales (K Doses) by Type (2026-2031)
Table 52. Global Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Pneumococcal Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Pneumococcal Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pneumococcal Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pneumococcal Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Pneumococcal Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2020-2025)
Table 59. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2026-2031)
Table 60. Global Pneumococcal Vaccine Sales (K Doses) by End User (2020-2025)
Table 61. Global Pneumococcal Vaccine Sales (K Doses) by End User (2026-2031)
Table 62. Global Pneumococcal Vaccine Sales Market Share by End User (2020-2025)
Table 63. Global Pneumococcal Vaccine Sales Market Share by End User (2026-2031)
Table 64. Global Pneumococcal Vaccine Revenue (US$ Million) by End User (2020-2025)
Table 65. Global Pneumococcal Vaccine Revenue (US$ Million) by End User (2026-2031)
Table 66. Global Pneumococcal Vaccine Revenue Market Share by End User (2020-2025)
Table 67. Global Pneumococcal Vaccine Revenue Market Share by End User (2026-2031)
Table 68. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2020-2025)
Table 69. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 73. Pfizer Pneumococcal Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 78. GSK Pneumococcal Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. MSD Company Information
Table 81. MSD Description and Business Overview
Table 82. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 83. MSD Pneumococcal Vaccine Product
Table 84. MSD Recent Developments/Updates
Table 85. Sanofipasteur Company Information
Table 86. Sanofipasteur Description and Business Overview
Table 87. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Sanofipasteur Pneumococcal Vaccine Product
Table 89. Sanofipasteur Recent Developments/Updates
Table 90. CDIBP Company Information
Table 91. CDIBP Description and Business Overview
Table 92. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 93. CDIBP Pneumococcal Vaccine Product
Table 94. CDIBP Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Pneumococcal Vaccine Distributors List
Table 98. Pneumococcal Vaccine Customers List
Table 99. Pneumococcal Vaccine Market Trends
Table 100. Pneumococcal Vaccine Market Drivers
Table 101. Pneumococcal Vaccine Market Challenges
Table 102. Pneumococcal Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pneumococcal Vaccine
Figure 2. Global Pneumococcal Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pneumococcal Vaccine Market Share by Type: 2024 & 2031
Figure 4. PPSV 23 Product Picture
Figure 5. PCV 7/13 Product Picture
Figure 6. PCV 10 Product Picture
Figure 7. Global Pneumococcal Vaccine Market Value by End User (2020-2031) & (US$ Million)
Figure 8. Global Pneumococcal Vaccine Market Share by End User: 2024 & 2031
Figure 9. Child
Figure 10. Adult
Figure 11. Global Pneumococcal Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Pneumococcal Vaccine Market Size (2020-2031) & (US$ Million)
Figure 13. Global Pneumococcal Vaccine Sales (2020-2031) & (K Doses)
Figure 14. Global Pneumococcal Vaccine Average Price (USD/Dose) & (2020-2031)
Figure 15. Pneumococcal Vaccine Report Years Considered
Figure 16. Pneumococcal Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global Pneumococcal Vaccine Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Pneumococcal Vaccine Players: Market Share by Revenue in Pneumococcal Vaccine in 2024
Figure 19. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Pneumococcal Vaccine Sales Market Share by Country (2020-2031)
Figure 22. North America Pneumococcal Vaccine Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Pneumococcal Vaccine Sales Market Share by Country (2020-2031)
Figure 26. Europe Pneumococcal Vaccine Revenue Market Share by Country (2020-2031)
Figure 27. Germany Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Pneumococcal Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Pneumococcal Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. China Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Pneumococcal Vaccine Sales Market Share by Country (2020-2031)
Figure 45. Latin America Pneumococcal Vaccine Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Pneumococcal Vaccine by Type (2020-2031)
Figure 55. Global Revenue Market Share of Pneumococcal Vaccine by Type (2020-2031)
Figure 56. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2020-2031)
Figure 57. Global Sales Market Share of Pneumococcal Vaccine by End User (2020-2031)
Figure 58. Global Revenue Market Share of Pneumococcal Vaccine by End User (2020-2031)
Figure 59. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2020-2031)
Figure 60. Pneumococcal Vaccine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Pneumococcal Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pneumococcal Vaccine Market Value by End User (2024 VS 2031) & (US$ Million)
Table 3. Global Pneumococcal Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pneumococcal Vaccine Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pneumococcal Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pneumococcal Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pneumococcal Vaccine Average Price (USD/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pneumococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pneumococcal Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pneumococcal Vaccine Sales by Region (2020-2025) & (K Doses)
Table 18. Global Pneumococcal Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Pneumococcal Vaccine Sales by Region (2026-2031) & (K Doses)
Table 20. Global Pneumococcal Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Pneumococcal Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pneumococcal Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Pneumococcal Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pneumococcal Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Pneumococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 27. North America Pneumococcal Vaccine Sales by Country (2026-2031) & (K Doses)
Table 28. North America Pneumococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pneumococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pneumococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Pneumococcal Vaccine Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Pneumococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pneumococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pneumococcal Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pneumococcal Vaccine Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Pneumococcal Vaccine Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Pneumococcal Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pneumococcal Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pneumococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Pneumococcal Vaccine Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Pneumococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pneumococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pneumococcal Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pneumococcal Vaccine Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East and Africa Pneumococcal Vaccine Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East and Africa Pneumococcal Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pneumococcal Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pneumococcal Vaccine Sales (K Doses) by Type (2020-2025)
Table 51. Global Pneumococcal Vaccine Sales (K Doses) by Type (2026-2031)
Table 52. Global Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Pneumococcal Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Pneumococcal Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pneumococcal Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pneumococcal Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Pneumococcal Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2020-2025)
Table 59. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2026-2031)
Table 60. Global Pneumococcal Vaccine Sales (K Doses) by End User (2020-2025)
Table 61. Global Pneumococcal Vaccine Sales (K Doses) by End User (2026-2031)
Table 62. Global Pneumococcal Vaccine Sales Market Share by End User (2020-2025)
Table 63. Global Pneumococcal Vaccine Sales Market Share by End User (2026-2031)
Table 64. Global Pneumococcal Vaccine Revenue (US$ Million) by End User (2020-2025)
Table 65. Global Pneumococcal Vaccine Revenue (US$ Million) by End User (2026-2031)
Table 66. Global Pneumococcal Vaccine Revenue Market Share by End User (2020-2025)
Table 67. Global Pneumococcal Vaccine Revenue Market Share by End User (2026-2031)
Table 68. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2020-2025)
Table 69. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 73. Pfizer Pneumococcal Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 78. GSK Pneumococcal Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. MSD Company Information
Table 81. MSD Description and Business Overview
Table 82. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 83. MSD Pneumococcal Vaccine Product
Table 84. MSD Recent Developments/Updates
Table 85. Sanofipasteur Company Information
Table 86. Sanofipasteur Description and Business Overview
Table 87. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Sanofipasteur Pneumococcal Vaccine Product
Table 89. Sanofipasteur Recent Developments/Updates
Table 90. CDIBP Company Information
Table 91. CDIBP Description and Business Overview
Table 92. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 93. CDIBP Pneumococcal Vaccine Product
Table 94. CDIBP Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Pneumococcal Vaccine Distributors List
Table 98. Pneumococcal Vaccine Customers List
Table 99. Pneumococcal Vaccine Market Trends
Table 100. Pneumococcal Vaccine Market Drivers
Table 101. Pneumococcal Vaccine Market Challenges
Table 102. Pneumococcal Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pneumococcal Vaccine
Figure 2. Global Pneumococcal Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pneumococcal Vaccine Market Share by Type: 2024 & 2031
Figure 4. PPSV 23 Product Picture
Figure 5. PCV 7/13 Product Picture
Figure 6. PCV 10 Product Picture
Figure 7. Global Pneumococcal Vaccine Market Value by End User (2020-2031) & (US$ Million)
Figure 8. Global Pneumococcal Vaccine Market Share by End User: 2024 & 2031
Figure 9. Child
Figure 10. Adult
Figure 11. Global Pneumococcal Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Pneumococcal Vaccine Market Size (2020-2031) & (US$ Million)
Figure 13. Global Pneumococcal Vaccine Sales (2020-2031) & (K Doses)
Figure 14. Global Pneumococcal Vaccine Average Price (USD/Dose) & (2020-2031)
Figure 15. Pneumococcal Vaccine Report Years Considered
Figure 16. Pneumococcal Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global Pneumococcal Vaccine Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Pneumococcal Vaccine Players: Market Share by Revenue in Pneumococcal Vaccine in 2024
Figure 19. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Pneumococcal Vaccine Sales Market Share by Country (2020-2031)
Figure 22. North America Pneumococcal Vaccine Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Pneumococcal Vaccine Sales Market Share by Country (2020-2031)
Figure 26. Europe Pneumococcal Vaccine Revenue Market Share by Country (2020-2031)
Figure 27. Germany Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Pneumococcal Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Pneumococcal Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. China Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Pneumococcal Vaccine Sales Market Share by Country (2020-2031)
Figure 45. Latin America Pneumococcal Vaccine Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Pneumococcal Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Pneumococcal Vaccine by Type (2020-2031)
Figure 55. Global Revenue Market Share of Pneumococcal Vaccine by Type (2020-2031)
Figure 56. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2020-2031)
Figure 57. Global Sales Market Share of Pneumococcal Vaccine by End User (2020-2031)
Figure 58. Global Revenue Market Share of Pneumococcal Vaccine by End User (2020-2031)
Figure 59. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2020-2031)
Figure 60. Pneumococcal Vaccine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232